Mainboard

IPO ·

BSE, NSE

Hexagon Nutrition Ltd

Listed

Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company.

Issue details

Price band

₹42 – ₹45

Face value

₹1

Lot size

333 shares

Minimum investment

₹14,985

Issue size

₹138.87 Cr

Fresh issue

—

Offer for sale

₹138.87 Cr

Issue type

Book Built

Exchange

BSE, NSE

Key dates

Opens

5 Jun 2026

Closes

9 Jun 2026

UPI mandate cut-off

5:00 PM on 9 Jun 2026

Allotment

10 Jun 2026

Refunds

11 Jun 2026

Shares in demat

11 Jun 2026

Listing

12 Jun 2026

Subscription and listing

Subscription

37.47x

Listing price

₹53.19

Registrar

Kfin Technologies Ltd

Lead manager

Cumulative Capital, Catalyst Capital Partners

Subscription by category

Total

37.47x

Total applications

7,53,804

Anchor investors

Amount raised

₹41.66 Cr

Bid date

4 Jun 2026

50% lock-in ends

9 Jul 2026

Rest lock-in ends

7 Sep 2026

Listing day

Issue price

₹45

Open

₹53.19

High

₹53.19

Low

₹53.19

Day close

₹53.19

Listing gain at open

+18.20%

Issue structure

Shares reserved per category and share of the total issue

QIB Shares Offered

1,54,29,851

50.00%

Anchor Investor Shares Offered

92,57,696

30.00%

QIB (Ex. Anchor) Shares Offered

61,72,155

20.00%

NII Shares Offered

46,28,956

15.00%

bNII > ₹10L

30,85,971

10.00%

sNII < ₹10L

15,42,985

5.00%

Retail Shares Offered

1,08,00,897

35.00%

Total Shares Offered

3,08,59,704

100.00%

Finaccle’s quick read

Neutral

FY25 income up 9%, PAT up 100%, ROE 13.02%, D/E 0.18, post-issue P/E 15.35x.

A rules-based screen of growth, margins, debt and valuation, built from the offer document and data on Chittorgarh.com. It is for information only and is not investment advice or a recommendation to buy or sell. Read the RHP and speak to a SEBI-registered adviser before you apply.

About the company

Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods. The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports.

Founded

1993

1993

Promoters

Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar, Nikhil Arun Kelkar

Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar, Nikhil Arun Kelkar

Promoter holding

89.41% pre-issue; 45.74% post-issue

89.41% pre-issue; 45.74% post-issue

Financial performance

Restated figures in ₹ crore, latest period first

₹ crore, latest first. Full table on desktop.

Period

Total income

Income

EBITDA

PAT

Net worth

Borrowings

Debt

Assets

Dec 2025

Dec 2025

275.57

275.57

37.55

27.03

27.03

223.05

39.79

39.79

327.60

FY25

FY25

331.29

331.29

40.07

24.38

24.38

195.60

26.60

26.60

261.36

FY24

FY24

304.62

304.62

24.88

12.21

12.21

176.29

36.89

36.89

250.54

FY23

FY23

281.65

281.65

17.17

5.82

5.82

163.84

51.87

51.87

288.90

ROE

13.02%

ROCE

14.82%

Debt / equity

0.18

PAT margin

9.81%

P/E post issue

15.35

Market cap

₹553.13 Cr

Use of IPO money

Strengths

✓

PAT up 100% in FY25 to ₹24.38 Cr

✓

Moderate leverage: debt to equity 0.18

Risks to watch

!

Entire issue is an offer for sale; company gets no fresh money

!

Modest PAT margin of 9.81%

Planning to take your own company public?

Every listing on this page started with a growing business that got its numbers, governance and paperwork ready for investors. If you are a promoter weighing an SME or main board IPO, we can tell you where you stand and what it will take.

Talk to our IPO Advisory team for readiness planning, or our IPO Consultancy team to run the listing end to end.

Last updated:

Information is compiled from exchange notices and the company’s offer document. It is for general information only and is not investment advice or a recommendation to apply. Read the prospectus before investing.